CRIS Current Research Information System

FONTANA, MARIA CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.918
AS - Asia 3.683
EU - Europa 2.631
AF - Africa 280
Continente sconosciuto - Info sul continente non disponibili 224
SA - Sud America 183
OC - Oceania 8
Totale 10.927
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.827
VN - Vietnam 1.314
SG - Singapore 877
CN - Cina 752
GB - Regno Unito 657
IT - Italia 459
SE - Svezia 341
DE - Germania 318
HK - Hong Kong 198
FR - Francia 169
IN - India 136
BR - Brasile 128
NL - Olanda 126
RU - Federazione Russa 117
IE - Irlanda 106
FI - Finlandia 77
TG - Togo 75
JP - Giappone 66
ZA - Sudafrica 59
BD - Bangladesh 57
CI - Costa d'Avorio 52
CA - Canada 50
NG - Nigeria 50
EE - Estonia 44
KR - Corea 41
UA - Ucraina 38
BE - Belgio 34
BG - Bulgaria 33
JO - Giordania 33
PH - Filippine 29
CH - Svizzera 27
ID - Indonesia 25
TH - Thailandia 24
SC - Seychelles 23
AR - Argentina 19
IQ - Iraq 19
PL - Polonia 16
UZ - Uzbekistan 16
TR - Turchia 14
TW - Taiwan 14
ES - Italia 13
GR - Grecia 13
IR - Iran 13
MX - Messico 13
AT - Austria 12
PK - Pakistan 11
CO - Colombia 9
EC - Ecuador 9
EU - Europa 8
AU - Australia 7
MY - Malesia 7
SA - Arabia Saudita 7
AE - Emirati Arabi Uniti 6
JM - Giamaica 6
MK - Macedonia 6
VE - Venezuela 6
HN - Honduras 5
PY - Paraguay 5
CL - Cile 4
CR - Costa Rica 4
EG - Egitto 4
ET - Etiopia 4
HR - Croazia 4
LT - Lituania 4
TT - Trinidad e Tobago 4
AL - Albania 3
DZ - Algeria 3
LB - Libano 3
MA - Marocco 3
NP - Nepal 3
PE - Perù 3
SV - El Salvador 3
BH - Bahrain 2
CY - Cipro 2
DK - Danimarca 2
KE - Kenya 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
PA - Panama 2
RO - Romania 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BW - Botswana 1
CG - Congo 1
CZ - Repubblica Ceca 1
GE - Georgia 1
GP - Guadalupe 1
GT - Guatemala 1
HU - Ungheria 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
Totale 10.703
Salva come PNG Salva come JPEG
Città #
Singapore 634
Southend 586
Dong Ket 521
Ashburn 449
Chandler 345
Fairfield 252
San Jose 209
Ann Arbor 203
Hong Kong 186
Ho Chi Minh City 175
Hanoi 169
Houston 152
Beijing 150
Wilmington 138
Seattle 134
Woodbridge 124
Cambridge 117
Dublin 105
Santa Clara 104
Princeton 98
Boardman 90
Bologna 83
Lomé 75
New York 67
Tokyo 58
Los Angeles 56
Abidjan 52
Council Bluffs 52
Nanjing 47
Helsinki 46
Lauterbourg 46
Westminster 45
Hefei 42
Padova 42
Medford 41
Munich 36
Abeokuta 34
Brussels 33
Sofia 33
Amman 32
Dallas 31
Milan 31
Haiphong 30
Frankfurt am Main 28
Seoul 26
Buffalo 25
Bremen 24
São Paulo 24
Berlin 23
Da Nang 23
Redondo Beach 23
Guangzhou 22
Saint Petersburg 22
Redwood City 21
Turin 21
Redmond 20
San Diego 20
Shanghai 19
Toronto 19
Bern 18
Florence 17
Hebei 17
Jinan 17
London 17
Lappeenranta 16
Nanchang 16
Phoenix 16
Shenyang 16
Changsha 15
Jakarta 15
Jiaxing 14
Rome 14
Turku 14
Atlanta 13
Biên Hòa 12
Hải Dương 12
Paris 12
San Francisco 12
Tianjin 12
Chengdu 11
Johannesburg 11
Nuremberg 11
Orem 11
Zhengzhou 11
Chennai 10
Chicago 10
Mountain View 10
Warsaw 10
Brooklyn 9
Falkenstein 9
Manchester 9
Norwalk 9
Vienna 9
Baghdad 8
Düsseldorf 8
Hangzhou 8
Montreal 8
Taizhou 8
Amsterdam 7
Athens 7
Totale 6.802
Salva come PNG Salva come JPEG
Nome #
Aneuploid acute myeloid leukemia exhibits a signature of genomic alterations in the cell cycle and protein degradation machinery 413
Chromothripsis in acute myeloid leukemia: Biological features and impact on survival 322
A Specific Pattern of Somatic Mutations Associates with Poor Prognosis Aneuploid Acute Myeloid Leukemia: Results from the European NGS-PTL Consortium 306
Aggressive Aneuploid Acute Myeloid Leukemia Is Dependent on Alterations of P53, Gain of APC and PLK1 and Loss of RAD50 294
Co-occurrence of alterations in the DNA damage repair genes synergize with uncontrolled proliferation and associate with very-poor prognosis in acute myeloid leukemia patients 281
Blinatumomab Is Safe and Effective in Relapsed and MRD Positive B-ALL CD19+ Patients: The Bologna Compassionate Program Experience 259
The alteration in key regulator genes of autophagy is mainstream mechanism of therapy resistance and impact prognosis of acute myelogenous leukemia (AML): results from diagnosis genomic analysis on 148 consecutive patients treated with intensive chemotherapy and long-term survival follow-up 258
Alterations of BRCA1 and PALB2 Define a Novel Class of Complex-Karyotype AML with a Very Bad Prognosis 257
Alterations in Pathways Regulating Phosphatidil Inositol 3 Phosphate (PI3P) Produce Both Cell Proliferation and Therapy Resistance, and Define a Group of Patients with Poor Prognosis in Acute Myeloid Leukemia (AML) 251
Targeting WEE1 to enhance conventional therapies for acute lymphoblastic leukemia 246
Inotuzumab ozogamicin is effective in relapsed/refractory extramedullary B acute lymphoblastic leukemia 244
Chromothripsis in Acute Myeloid Leukemia Is Strongly Associated with Poor Prognosis and TP53 Alterations 242
MEC (mitoxantrone, etoposide, and cytarabine) induces complete remission and is an effective bridge to transplant in acute myeloid leukemia 237
Chromothripsis in AML patients: A new mechanism of cancer initiation and progression 236
A cell cycle-related genomic and transcriptomic signature distinguish aneuploid and euploid acute myeloid leukemia 236
Integrated genomic-metabolic classification of acute myeloid leukemia defines a subgroup with NPM1 and cohesin/DNA damage mutations 224
Distinct pattern of alterations in tp53 mutated and wild type acute myeloid leukemia (AML) patients 219
SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis 215
Novel Genomic Patterns of Metabolic Remodeling in Acute Myeloid Leukemia 215
Copy number variants signature in two patients with relapsed acute promyelocytic leukemia 213
A new biomarker of response to 5-azacitidine therapy in MDS and AML patients: SIRPB1 211
Deficient necroptosis pathway as a negative prognostic factor in acute myeloid leukemia. 207
Microarray analysis to identifiy novel copy number alterations in acute myeloid leukemia 205
Impact on survival of catastrophic karyotype events in 101 consecutive acute myeloid leukemia (AML) patients: High risk karyotype and chromothripsis 197
MHC-I Antigen Presentation Role in Immune Escape of Acute Myeloid Leukemia with High Burden of Genomic Aberration 197
Loss of PALB2 predicts poor prognosis in acute myeloid leukemia and suggests novel therapeutic strategies targeting the DNA repair pathway 195
SIRPB1 Is a Strong Predictor Biomarker of Response to 5-Azacitidine Therapy in MDS and AML Patients 194
Survival analysis of patients carrying different FLT3 mutations (internal tandem duplication (ITD) and tyrosine kinase domain (TKD) mutations) in 459 consecutive non M3 newly diagnosed acute myeloid leukemia (AML) 193
Gemtuzumab-Ozogamicin Containing Regimens As Induction Therapy Give the Highest Complete Remission Rate and the Longest Overall Survival Compared with Other Induction Regimens in Patients with Newly Diagnosed Acute Myeloid Leukemia 189
TP53 mutations are mutually exclusive with FLT3 and NPM mutations in AML patients and are strongly associated with complex karyotype and poor outcome 186
Prognostic significance of alterations of pathways regulating autophagy in acute myeloid leukemia 184
The Genomic and Transcriptomic Landscape of Systemic Mastocytosis 178
Survival and outcome data observed in 98 patients affected by acute myeloid leukemia undergoing chemotherapy consolidation courses treatment followed by autologous bone marrow transplantation (auto-BMT) 177
Two or More Chemotherapy Consolidation Courses, Followed By Autologous Bone Marrow Transplantation, and MRD Negativity, Give Long Term Overall Survival in Acute Myeloid Leukemia Patients 177
Effect of production process and high-pressure processing on viability of Listeria innocua in traditional Italian dry-cured coppa 175
You have accessAlterations in Pathways Regulating Phosphatidil Inositol 3 Phosphate (PI3P) Produce Both Cell Proliferation and Therapy Resistance, and Define a Group of Patients with Poor Prognosis in Acute Myeloid Leukemia (AML) 172
SNP array reveals a new deletion of JAK2 in AML patients 172
A Three-Genes Signature of Anti-Apoptotic Genes Showed Different Mechanisms in Preventing Apoptosis in Acute Myeloid Leukemia Cells and Could Provide an Useful Model to Establish the Proper BH3-Mimetich Drug or Combination 171
Genome-Wide Molecular Portrait of Aggressive Systemic Mastocytosis and Mast Cell Leukemia Depicted By Whole Exome Sequencing and Copy Number Variation Analysis 162
Survival analysis of 409 consecutive patients with newly diagnosed acute myeloid leukemia treated with intensive induction therapy, with or without the addition of gemtuzomab-ozagomicin (GO) 162
Genomic wide microarray analysis identifies novel copy number alterations in adult acute myeloid leukemia 162
SETD2 Non-Genomic Loss of Function and p53 Functional Inactivation in Advanced Systemic Mastocytosis (SM): Pathogenetic and Therapeutic Implications 160
Separase overexpression defines a new subset of acute myeloma leukemia patients characterized by high CD34 and MYC levels 160
Specific chromosomic alterations confer therapy resistance in a cohort of 49 patients with newly diagnosed acute myeloid leukemia treated with intensive chemotherapy 159
Genomic-Wide Analysis By High Resolution SNP Array Identifies Novel Genomic Alteration in Acute Myeloid Leukemia 156
Single nucleotide polymorphisms as genomic markers for high-throughput pharmacogenomic studies 152
Effect of production process and high-pressure processing on viability of Salmonella spp. in traditional Italian dry-cured coppa 145
Author Correction: Genome-wide association study identifies susceptibility loci for acute myeloid leukemia (Nature Communications, (2021), 12, 1, (6233), 10.1038/s41467-021-26551-x) 141
Pharmacological interaction and side effects in oncohaematology: a retrospective observational study 133
Release of IFNg by Acute Myeloid Leukemia Cells Remodels Bone Marrow Immune Microenvironment by Inducing Regulatory T Cells 131
New JAK2 heterozygous loss: A role in overall survival in acute myeloid leukemia patients 125
Pharmacological Inhibition of WIP1 Sensitizes Acute Myeloid Leukemia Cells to the MDM2 Inhibitor Nutlin-3a 110
EFFETTO DELL’AZIONE DEI RAGGI INFRAROSSI SULLA CARICA BATTERICA PATOGENA DI LATTE CRUDO VACCINO 81
Genome-wide association study identifies susceptibility loci for acute myeloid leukemia 76
PREVALENCE OF SALMONELLA ENTERICA SUBSP. ENTERICA IN HEDGEHOG (ERINACEUS EUROPAEUS) IN FERRARA PROVINCE (EMILIA ROMAGNA, ITALY) 73
Acute myeloid leukemia mutations: Therapeutic implications 57
Common variation at 1q23.3, 2p23.3, 2q33.3, and 2p21 influences the risk of acute myeloid leukemia 34
Totale 10.927
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.358
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.358
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022976 0 0 53 117 114 56 31 63 57 71 228 186
2022/20231.380 155 202 73 185 105 104 36 67 251 30 119 53
2023/2024394 15 49 17 47 24 101 30 27 21 30 21 12
2024/20251.376 36 217 139 100 110 38 178 62 14 162 74 246
2025/20263.325 311 189 215 212 340 153 270 88 954 316 149 128
2026/2027343 92 117 134 0 0 0 0 0 0 0 0 0
Totale 10.927